Hypertension Diagnostics HDII · USD

Its shares trade under the ticker HDII. It has been listed since 23 July 1998. In the fiscal year to 31 December 2019, it reported revenue of $3.8m and net income of $3.3m. At that date it held total assets of $1.1m and shareholders' equity of −$1.0m.

Hypertension Diagnostics, Inc. engages in the business of plastic reprocessing. The company is headquartered in Minneapolis, Minnesota. The firm offers CVProfilor DO-2020, CVProfilor MD-3000 and HD/PulseWave CR-2000. The CVProfilor DO-2020 is a non-invasive System designed to provide physicians in the United States with a means for assessing a patient's vascular health. The CVProfilor DO-2020 provides a patient's arterial elasticity indices, which can be used in the assessment for underlying vascular disease. The CVProfilor MD-3000 provides a guide to the presence of blood vessel disease. The HD/PulseWave CR-2000 is a non-invasive System designed for research purposes. The HD/PulseWave CR-2000 Research CardioVascular Profiling System provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in a range of areas, including pharmaceutical studies, endothelial function, aging and women's health.

Figures and description from our data supplier, not checked against the company's own report.

• Kenneth BrimmerChief Executive Officer, Chief Financial Officer, Director, since 1995$287,697
• Larry LeitnerIndependent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.